Titan Medical Inc. Ordinary Shares
TMDI
TMDI was delisted on the 9th of March, 2023.
68 hedge funds and large institutions have $2.03M invested in Titan Medical Inc. Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 6 closing their positions.
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
7% more capital invested
Capital invested by funds: $1.91M → $2.03M (+$126K)
3% more funds holding
Funds holding: 66 → 68 (+2)
27% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EL
Essex LLC
Deer Park,
Illinois
|
+$181K |
| 2 |
KPWS
Kestra Private Wealth Services
Austin,
Texas
|
+$15.4K |
| 3 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$15.4K |
| 4 |
Morgan Stanley
New York
|
+$14.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$13.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$45K |
| 2 |
Renaissance Technologies
New York
|
-$42.6K |
| 3 |
VF
Virtu Financial
New York
|
-$39K |
| 4 |
LSA
Leonteq Securities AG
Zurich,
Switzerland
|
-$9.79K |
| 5 |
Two Sigma Advisers
New York
|
-$6.17K |
TMDI Hedge Fund Activity: Q2 2022 in Review
68 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Titan Medical Inc. Ordinary Shares (TMDI) for Q2 2022, worth a combined $2.03M — up 6.6% from $1.91M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new TMDI positions and 6 closed out — a net gain of 2 holders — while 11 added to existing stakes and 15 trimmed.
The largest buyer was Essex LLC, adding an estimated $181K. The largest seller was Citadel Advisors, cutting an estimated $45K.
- 68 institutional investors held Titan Medical Inc. Ordinary Shares (TMDI) as of Q2 2022, up from 66 in Q1 2022.
- Funds reported $2.03M of Titan Medical Inc. Ordinary Shares stock for Q2 2022, up 6.6% quarter-over-quarter.
- 8 funds opened new Titan Medical Inc. Ordinary Shares positions in Q2 2022 and 6 closed out, a net change of +2 holders.
- The largest Titan Medical Inc. Ordinary Shares buyer in Q2 2022 was Essex LLC, an estimated $181K added.
- The largest Titan Medical Inc. Ordinary Shares seller in Q2 2022 was Citadel Advisors, an estimated $45K sold.
Based on aggregated 13F filings for Q2 2022.